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Antimicrobial resistance (AMR) is now well recognised 
as a global health threat[1] that impacts on human health 
and may potentially have a major effect on the global 
economy.[2] The United States Centers for Disease Control 
and Prevention (CDC) has identified four core actions to 
combat this challenge, i.e. surveillance, antibiotic stewardship, improved 
drugs and diagnostics, and preventing spread.[3] While infection control is 
a very broad topic, this article focuses on measures to prevent the spread 
of multidrug-resistant organisms (MDROs) in healthcare settings and 
interventions to prevent infection.
Transmission of multidrug-resistant 
organisms 
Transmission of any infectious agent (whether multidrug resistant or 
not) implies the presence of a source of the organism, a susceptible host, 
and a transfer mechanism. Most infectious agents in the healthcare 
setting are transmitted from humans (most commonly patients, but also 
healthcare workers (HCWs) or visitors), although transmission from 
environmental sources has also been well described.[4,5] The greater the 
number of patients colonised with a particular MDRO (the ‘colonisation 
pressure’), the greater the chance of transmission.[5] Colonised HCWs 
have also been implicated in the transmission of infectious agents,[6] but 
are thought to be a far less common source.[5] 
Although organisms can be transmitted to any patient in hospital, 
certain patients are at higher risk of colonisation (and therefore 
of potential infection), including those with underlying medical 
conditions, those with compromised defences (such as indwelling 
devices, burns), and those who have undergone recent surgery. 
There are three broad mechanisms by which organisms can be 
transmitted in healthcare settings:[4] contact, droplet transmission 
and airborne transmission. Droplet transmission refers to organisms 
spread by large respiratory droplets (e.g. pertussis, diphtheria, certain 
respiratory viruses), while airborne transmission applies to organisms 
spread on droplet nuclei that remain suspended for prolonged 
periods (e.g. Mycobacterium tuberculosis, measles, varicella). Neither 
of these are a major route of transmission for MDROs, except for 
MDR tuberculosis, which is not the focus of this article.
Contact spread is the most important means of transmission 
for the vast majority of MDROs in healthcare settings, and can be 
either direct or indirect. Direct contact transmission occurs when 
an infected or colonised person comes into physical contact with a 
susceptible host. Indirect contact transmission implies the presence 
of some intermediate vehicle – either human or an inanimate object. 
Although transmission by items such as contaminated equipment, 
shared toys and poorly sterilised equipment is possible, the most 
important means of transmission is via the hands of HCWs.
Prevention of transmission
As the hands of HCWs are the most important means of transmission 
of MDROs, the importance of hand hygiene cannot be overstated. A 
number of studies have shown that improvements in hand hygiene 
are associated with lower healthcare-associated infection rates, and/or 
reductions in MDRO transmission and acquisition.[7-10] Nonetheless, 
compliance with hand hygiene recommendations is often poor, with 
studies reporting rates as low as 20 - 30%.[11-13] 
The adequate disinfection of hands is easily accomplished by using 
an alcoholic hand rub, with or without additional disinfectants, e.g. 
chlorhexidine. The alcohol is responsible for the immediate killing of 
transient flora on the hands, while the additional agents may exert a 
residual effect, limiting reacquisition of organisms for a limited period 
(although the evidence is mainly based on in vitro simulations, and the 
additional benefit of preventing transmission has not been studied well). 
Alcohol hand rubs are superior to both ordinary soap and water 
and medicated soap and water with regard to the efficacy of removal 
of micro-organisms. This is based on numerous in vitro simulations 
and clinical evidence.[14] As an example, a 6-year observation study 
at a tertiary centre in the USA compared 3 years of medicated soap 
use with 3 years of alcoholic hand rub use, and showed reductions 
in acquisition of both methicillin-resistant Staphylococcus aureus 
(MRSA) and vancomycin-resistant Enterococcus (VRE) (21% and 
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41% reductions, respectively).[15] This may 
be due to the greater efficacy of alcohol and 
improved compliance with hand hygiene, 
with hand rubs being more easily accessible. 
Alcohol hand rubs can be manufactured very 
easily and cheaply if commercial products 
are not available. One suggested recipe is as 
follows:[14]
• ethanol 96% v/v, 833.3 mL
• hydrogen peroxide (H2O2) 3%, 41.7 mL
• glycerol 98%,14.5 mL.
Make up to 1 000 mL with distilled water or 
boiled and cooled water and shake gently to 
mix the contents.
H202 is added to help eliminate contam-
inating spores in the bulk solutions, and 
glycerol acts as an emollient to improve 
acceptability. Neither of these items plays a 
role in the actual hand disinfection process.
Other important factors to remember with 
regard to the use of alcohol-based hand rubs are:
• If hands are visibly soiled, they should first 
be cleaned with soap and water – before 
using hand rubs. 
• Alcohol is less effective at removing spores; 
hence, when caring for patients with 
suspected or confirmed Clostridium difficile 
infections, medicated soap is preferred.
The World Health Organization is promo-
ting the ‘Your 5 Moments for Hand Hygiene’ 
campaign (Fig. 1),[14,16] which recommends 
that hand hygiene be practised as follows:
• before patient contact
• before a clean or aseptic procedure
• after contact with body fluids
• after patient contact
• after contact with the patient’s environment.
Measures beyond hand 
hygiene
Other measures have been advocated to 
reduce the risk of transmission of MDROs. 
The CDC[4] recommends that all patients 
colonised or infected with epidemiologically 
important pathogens (including MDROs) 
that are spread by contact be placed on 
contact precautions. This consists of isolating 
the patient in a room (or placing the patient 
with others with the same organism), use 
of gloves for all patient contact, and use of 
gowns/aprons during patient contact. Where 
isolation rooms are limited, patients with 
MDROs may need to be nursed in open 
wards. However, even there, every effort 
should be made to implement the glove and 
gown components of contact precautions. 
These recommendations are based on expert 
opinion and knowledge of the transmission 
mechanism, but there is limited evidence 
that contact precautions make a significant 
difference to transmission of MDROs, over 
and above good hand hygiene and adherence 
to basic infection control principles.[5,17-19] 
Many studies include multiple interventions 
(improved staffing levels, education 
campaigns, hand hygiene campaigns) in 
addition to contact precautions, and it is 
difficult to identify which has the greatest 
impact. 
There have been concerns about the 
impact of isolation on the mental wellbeing of 
patients.[20] The additional burden of having 
patients on contact precautions may lead to 
a reduction in HCW compliance with these 
precautions.[21] Even given these concerns, 
there is evidence that implementation of 
contact precautions does improve hand 
hygiene compliance,[19] and it is still 
recommended for patients with MDROs. 
However, the importance of adequate 
staffing to sustain contact precautions and 




There is good evidence that active screening 
of preoperative patients for MRSA, with 
decolonisation of carriers, results in 
reductions in postoperative sepsis caused 
by MRSA and other pathogens.[22] The same 
effect has been described where all patients 
were decolonised with nasal mupirocin and 
chlorhexidine washes without the added 
cost of screening.[23] Chlorhexidine washes 
alone have also been shown to reduce the 
Fig. 1. The World Health Organization’s ‘Your 5 Moments for Hand Hygiene’ campaign.[14,16]
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acquisition of MDROs and development of healthcare-associated 
bacteraemia by 23% and 28%, respectively.[24] This raises the question 
of whether the application of intranasal mupirocin has benefit over 
chlorhexidine washes. The effect of chlorhexidine washes or wipes 
on infections with MDR Gram-negative bacteria specifically has 
not been as well described, and this, together with the descriptions 
of emerging chlorhexidine resistance, has led to some concerns 
about the implementation of routine chlorhexidine washes as a 
decolonisation strategy.[25] 
Surveillance cultures for carbapenem-resistant Enterobacteriaceae 
(CRE) have been advocated in a number of reports and 
recommendations as part of an overall strategy to combat this 
specific MDRO.[26,27] Screening has been a part of successful CRE 
control measures described in a variety of settings.[28,29] However, as 
before, all these studies have included other interventions and it is 
very difficult to determine the effect of surveillance cultures alone on 
CRE control. There is evidence that CRE can be controlled without 
the use of surveillance cultures,[18] and in resource-limited settings in 
particular it may be more appropriate to increase overall infection 
control capacity than to focus on screening. 
Decolonisation strategies have not been well described for any 
of the resistant Gram-negative organisms. Some studies have 
demonstrated emergence of resistance during CRE decolonisation 
regimens (which usually include colistin),[30-32] and this, allied to 
limited evidence of its efficacy, strongly suggests that decolonisation 
for multiresistant Gram-negative bacteria should not be attempted. 
If active screening for CRE carriage is carried out, the main 
intervention for carriers consists of isolation/cohorting and 
enhanced infection control measures. The duration of isolation 
for CRE (and for many other MDROs) is not well defined. CRE 
can be carried for ≥12 months,[33] and if patients are identified as 
CRE carriers, it may be valuable to be able to identify them on 
readmission to hospital. Screening to document elimination of 
carriage can be attempted; however, it has been suggested that there 
should be at least two negative cultures (and possibly a negative 
polymerase chain reaction test) before a known CRE carrier patient 
can be regarded as no longer carrying this organism.[34] This is an 
area where more research is required.
Prevention of infection
While many infection control interventions focus on reducing the 
transmission of organisms, it is as important to identify measures to 
reduce the risk of infection. Fewer infections translate into reductions 
in antibiotic use and better patient outcomes. Many professional 
bodies and groups have adopted the use of ‘care bundles’, whereby 
different interventions focused on the same infection are combined 
and practised as a standard of care. In South Africa, this is being 
driven by the ‘Best Care … Always’ (BCA) campaign (http://www.
bestcare.org.za/home). The four infections addressed by the BCA 
bundles are catheter-associated urinary tract infection (CA-UTI), 
ventilator-associated pneumonia (VAP), central line-associated 
bloodstream infection (CLABSI), and surgical site infection (SSI). 
Although there are some differences in the components of the 
bundles drawn up by different groups, and there is room for addition 
or modification, the components of the BCA bundles are as follows:
CA-UTI
• Avoid unnecessary catheterisation
• Insert catheters using an aseptic technique
• Maintain catheters based on recommended guidelines
• Review the need for catheterisation daily and remove the catheter 
as soon as possible.
VAP
• Elevation of the head of the bed to 45° (or 30° if 45° not possible)
• Subglottic drainage of secretions
• Assess readiness for extubation daily 
• Oral care and cleaning with chlorhexidine
• Initiation of enteral feeding within 24 - 48 hours of admission.
CLABSI
• Maximal barrier precautions when inserting line
• Chlorhexidine antisepsis when inserting line
• Selection of optimal catheter insertion suite (weighing infection 
and complication risks)
• Hand hygiene when caring for line
• Review the need for line daily, and remove as soon as possible.
SSI
• Appropriate antibiotic prophylaxis (timing, choice, duration)
• Appropriate hair removal (clippers or depilatory creams, not 
shaving)
• Postoperative glucose control
• Maintain postoperative normothermia.
Although some of the abovementioned components may be difficult 
to implement, the majority are relatively simple, require minimal 
resources, and when implemented can result in a dramatic reduction 
in infection. The incidence of SSI after colorectal surgery was 2% 
in patients who received all six components of a bundle, and 17% in 
those who received only one component.[35] A multicentre before-and-
after study in Korea showed a reduction in VAP rates from 4.08/1 000 
ventilator-days to 1.16/1 000 ventilator-days after implementation of a 
VAP bundle.[36] Reductions in VAP rates after implementing bundles 
have been associated with reduced ventilation-days and length of stay 
in the intensive care unit (ICU).[37] 
Implementation of CLABSI bundles has resulted in reductions 
in CLABSI rates of up to 56%;[38] despite different studies using 
different bundles, there is a consistent reduction in the rates of 
these infections.[38-40] Introduction of bundles for CLABSI, VAP and 
CA-UTI in ICUs of a Saudi Arabian hospital resulted in reductions 
in the rates of all three infections (86% for VAP, 63% for CLABSI and 
50% for CA-UTI).[41] 
Conclusion
Infection control has a major role to play in combating the threat of 
AMR, and many interventions that have proven benefit are relatively 
inexpensive. Chief among these is hand hygiene. The challenge 
remains the appropriate implementation of these interventions, and 
sustaining them once immediate threats are over. Infection control 
should no longer be seen as the sole responsibility of the infection 
control practitioner, but that of every HCW.
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